CSCRX
Price
$42.58
Change
-$0.79 (-1.82%)
Updated
Jul 2 closing price
Net Assets
3.73B
WCMNX
Price
$15.64
Change
-$0.15 (-0.95%)
Updated
Jul 2 closing price
Net Assets
55.43M
Interact to see
Advertisement

CSCRX vs WCMNX

CSCRX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
CSCRX vs. WCMNX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCRX is a Buy and WCMNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSCRX has more cash in the bank: 3.73B vs. WCMNX (55.4M). CSCRX (0.00) and WCMNX (0.00) have matching dividends . CSCRX was incepted earlier than WCMNX: CSCRX (13 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than CSCRX (0.88). CSCRX is a more actively managed with annual turnover of: 122.00 vs. WCMNX (89.00). CSCRX has a lower initial minimum investment than WCMNX: CSCRX (0) vs WCMNX (1000). CSCRX annual gain was more profitable for investors over the last year : 43.90 vs. WCMNX (25.72). CSCRX return over 5 years is better than : 19.47 vs. WCMNX (-0.19).
CSCRXWCMNXCSCRX / WCMNX
Total Expense Ratio0.881.2471%
Annual Report Gross Expense Ratio0.882.0443%
Fund Existence13 years7 years-
Gain YTD25.82715.424167%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.73B55.4M6,726%
Annual Yield % from dividends0.000.00-
Returns for 1 year43.9025.72171%
Returns for 3 years90.7731.54288%
Returns for 5 years19.47-0.19-10,171%
Returns for 10 years145.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZESX14.600.07
+0.48%
Lazard International Equity Select Open
BRMIX17.770.03
+0.17%
iShares Russell Mid-Cap Index Instl
RETSX104.400.10
+0.10%
Russell Inv Tax-Managed US Large Cap S
IVINX41.590.02
+0.05%
Nomura Global Growth Fund Class A
NAEFX89.070.01
+0.01%
New Alternatives Investor